Pine Valley Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pine Valley Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58M	Sell	10,010 -1,538	-13%	-$208K	0.06%	249
2026 Q1	$1.48M	Buy	11,548 +1,382	+14%	+$173K	0.07%	249
2025 Q4	$1.24M	Buy	10,166 +629	+7%	+$72.1K	0.06%	250
2025 Q3	$956K	Buy	9,537 +1,154	+14%	+$104K	0.05%	270
2025 Q2	$695K	Sell	8,383 -2,072	-20%	-$165K	0.04%	303
2025 Q1	$848K	Buy	10,455 +1,610	+18%	+$144K	0.05%	275
2024 Q4	$797K	Sell	8,845 -1,542	-15%	-$149K	0.05%	269
2024 Q3	$1.03M	Buy	10,387 +2,577	+33%	+$253K	0.06%	240
2024 Q2	$724K	Buy	7,810 +3,007	+63%	+$270K	0.05%	263
2024 Q1	$456K	Buy	4,803 +2,339	+95%	+$217K	0.03%	327
2023 Q4	$220K	Buy	+2,464	New	+$183K	0.02%	440

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WJWM

Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return

OPCM

Osborne Partners Capital Management San Francisco, California $1.8B AUM 22.23% 1-Year Est. Return

Pine Valley Investments's XBI Position: Q2 2026 in Review

Pine Valley Investments reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 13% in Q2 2026, selling an estimated $208K and leaving 10,010 shares worth $1.58M. The position accounts for 0.06% of the portfolio, ranked #249.

Pine Valley Investments first reported a position in XBI in Q4 2023 and has held it in 11 quarters since. 488 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Pine Valley Investments held 10,010 shares of State Street SPDR S&P Biotech ETF worth $1.58M as of Q2 2026.
Pine Valley Investments sold 1,538 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $208K.
State Street SPDR S&P Biotech ETF made up 0.06% of Pine Valley Investments's portfolio in Q2 2026, its #249 holding.
Pine Valley Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 11 quarters since.
488 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.